Quarterly report pursuant to Section 13 or 15(d)

Intangible Assets - Narrative (Details)

v3.21.1
Intangible Assets - Narrative (Details) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Intangible assets    
Amortization of intangible assets $ 47 $ 36
Sales and Marketing Expense    
Intangible assets    
Royalty fees included in sales and marketing expense $ 641 $ 492
License agreements    
Intangible assets    
Notice period for termination of license agreements 60 days  
Minimum royalty of agreements $ 13  
Milestone fee upon receiving a Phase II Small Business Innovation Research 15  
Milestone fee upon FDA approval 2  
Milestone fee upon first commercial use of certain licensed technology 25  
Milestone fee upon first use to manufacture products that utilize certain technology not currently incorporated into AxoGen products $ 10  
Minimum | License agreements    
Intangible assets    
Amortization period of intangible assets 17 years  
Royalty fees range under the license agreements 1.00%  
Maximum | License agreements    
Intangible assets    
Amortization period of intangible assets 20 years  
Royalty fees range under the license agreements 3.00%  
Royalty stack cap for royalties paid to more than one licensor for sales of the same product 3.75%  
Maximum | Patents    
Intangible assets    
Amortization period of intangible assets 20 years